HomeNewsBusinessEconomyForget bi-annual appraisals in 2020 as India Inc rushes to save costs amid COVID-19

Forget bi-annual appraisals in 2020 as India Inc rushes to save costs amid COVID-19

With little clarity on the lifting of lockdown, appraisal processes have been put off indefinitely.

June 05, 2020 / 14:18 IST
Story continues below Advertisement

A Mumbai-based financial services firm had in April 2020 assured its employees that the bi-annual appraisal in the second half of the year could bring some cheer. But in the last week of May, the employees were told that no appraisal would be done this year due to the COVID-19 pandemic.

“We were hoping for a revision in pay even as all our incentives have been cut down due to the coronavirus outbreak. However, this year there will be none,” a senior sales executive at the firm said.

Story continues below Advertisement

Several companies follow the bi-annual appraisal calendar to give employees who miss out on a raise or a promotion in the March cycle another shot in the September cycle.

The lockdown, which was announced on March 25 and has been extended till June 30  in some areas, brought the economy to a halt, leading to uncertainty among businesses.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show